Learning More About Robotic Hair Transplant Procedures
Washington Medical Hair Clinics is constantly reviewing & applying new scientific and technical improvements in hair transplantation. We are also personally active in researching new developments so that even better techniques may be developed in the future. High-tech research is providing new hope. And while these methods are still some way from becoming commercially available just yet, cloning, medications and gene therapy may one day reduce limitations in the donor area. WMHC is offering $3.00 Per Unit/Graft with voucher. *Certain Restrictions Apply
The FIRST to offer The ARTAS® Procedure in the Washington DC – Metro Area – The most experienced Artas Provider in the area and the FIRST to be awarded the Prestigious “Center of Excellence” from Restoration Robotics.
Now you can have a permanent and natural looking solution for hair loss. And nobody has to know you’ve had treatment.
ARTAS® Robotic Assisted FUE
Washington Medical Hair Clinics is the first to bring the ARTAS® Robotic Assisted FUE (Follicular Unit Extraction) procedure to the Washington DC Metro Area, Virginia & Maryland, as well as the Mid Atlantic Region in the United States. The ARTAS® Robotic Assisted FUE is the latest technology in hair transplant surgery. We are also the first and only to receive the prestigious Center of Excellence Award from Restoration Robotics.
The ARTAS® procedure is a computer-assisted, image-guided and doctor controlled robot for use with a FUE Hair Transplant. The ARTAS® System uses sophisticated imaging technology to map out the follicular units on your head. It then chooses the optimal grafts to extract with precision before quickly and carefully harvesting each follicular unit of one, two, three, or even four hairs.
We guide the ARTAS® through the entire FUE procedure before the grafts are removed and placed in the exact angle and pattern of your natural hair growth. The result is a natural looking head of hair with minimal downtime.
The advantages of the ARTAS® Robotic Assisted FUE:
- Increased precision of harvesting and survival of grafts
- Higher number of follicular units in one session
- Minimal downtime
- No linear scar
The ARTAS® procedure is FDA-cleared for light skinned and dark haired men. Therefore, in some cases, men with light hair will be asked to dye their hair darker on the day of their scheduled ARTAS® Robotic Assisted FUE procedure for optimum results. This can be done by us the morning you arrive.
After your ARTAS® Robotic Assisted FUE procedure, the donor region will be mostly healed after one week with improvement in the recipient area in as little as six to twelve months.
As a final consideration, you should be aware that not all patients are candidates for the ARTAS® Robotic Assisted FUE.
You’ll have natural looking hair — your own hair — that you can wear in any style with confidence.
Hair Restoration RedefinedTM:
- Minimally invasive, outpatient procedure
- Quick recovery
- Permanent hair restoration results
- Great for repairing widened strip/linear scars
- Eyebrow/Facial Hair Restoration
- Minimal Discomfort
A cure for baldness? Researchers develop method for growing new human hair.
By John RobertsPublished October 21, 2013FoxNews.com
Scientists in the U.S. and Britain may have taken a huge leap forward in finding a cure for baldness – one that may be available in the clinical setting within a few years.
For the first time, researchers at Columbia University Medical Center in New York City and the University of Durham have generated new hair follicles that grow human hair. According to lead researcher Angela Christiano, associate professor of molecular dermatology at Columbia, this discovery has the potential to “revolutionize” the medical treatment. Check out the video here.
Latisse Tested as Hair Loss Treatment
Hot on the heels of fuller eyelashes becoming a trend in cosmetic treatments, according to the New York Times, Latisse, a topical treatment that can help you grow fuller lashes is being tested as a treatment for patients with alopecia.
Though many individuals use Latisse to attain “disco-ready lashes without using falsies,” the new clinical trials being conducted by Allergan, the company that produces Latisse, may prove the product’s effectiveness north of the brow line.
The study, which includes both men and women and is due to be completed in February, is working to determine whether bimatoprost, the ingredient in Latisse that promotes eyelash growth, can also work as a hair loss treatment, according to clinicaltrials.gov.
As it is traditionally applied, Latisse prolongs the growth cycle of your lashes. Due to this lengthened growth cycle, your lashes can grow longer and in greater number.
The thinking behind gene therapy is to introduce new DNA into a patient’s hair cells. This new DNA will then prevent cells from being affected by the dihydrotestosterone (DHT) hormone that is responsible for Male Pattern Baldness.
However, the study is still in its infancy. And despite certain genes being identified to cause hair loss, there are still a large number of other factors causing hair loss. With this in mind, a great deal of research needs to be done before gene therapy becomes a reality.
Cloning hair follicles is a fairly new technology. Considered something of a Holy Grail for people suffering from hair loss because of its promise of an unlimited supply of hair from a single strand, the method is keenly debated. And although it is an exciting breakthrough, it will require another ten years of research before the method is commercially available.
There are currently two organizations that are conduction serious research into developing a commercially viable way of multiplying bald resistant donor follicles. They are Aderans headquartered in Japan and Intercytex based in England.
Hair cloning is a lay term for tissue developed hair growth. The approach currently underway involves extracting single hair cells from the hair-loss-resistant donor area and attempting to replicate in the laboratory. These “dermal papilla” cells mature into hair follicles in a process known as follicular neogenesis. If they can be stimulated to multiply, then theoretically there could be no limit to the number that could be grown in the laboratory and then transplanted back into the scalp from which they originated.
However, controlling the direction of new hair growth has been problematic. Many believe that such hair cell implantation will initially be used as filler hair, primarily on the top and crown area, with critical areas such as the hairline being transplanted using conventional FUE grafts. The cost of this laboratory intensive procedure is also expected to exceed conventional hair transplantation when introduced.
At this point in time, it is not recommended that patients wait for cloning. If and when hair cell implantation does arrive in the future, it could well be used to create even greater levels of density and fullness behind the transplanted hairline.